Fundraising FoxDialybrid
1 known investors
Find your way into Dialybrid
Sign up to see every warm intro you have to Dialybrid
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dialybrid team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dialybrid develops vascular grafts for hemodialysis using Silkothane®, a hybrid material combining silk fibroin and polyurethane, targeting nephrologists and dialysis centers. The company focuses on advanced biomedical devices in the tissue engineering and regenerative medicine sector.
Founders & leadership
FG
Francesco GrecoChief Executive OfficerHe brings experience in the medical device industry with expertise in R&D and FDA regulation, and holds a degree from Politecnico di Milano.
Investors · 1
Frequently asked questions
- What does Dialybrid do?
- Dialybrid develops vascular grafts for hemodialysis using Silkothane®, a hybrid material combining silk fibroin and polyurethane, targeting nephrologists and dialysis centers. The company focuses on advanced biomedical devices in the tissue engineering and regenerative medicine sector.
- Who are Dialybrid's investors?
- Dialybrid's investors include LIFTT.